Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.018
F. C. Freitas, M. R. Sanches, AdC Dosatti
Hydroceles are abnormal collection of fluid between the parietal and visceral layers of the tunica vaginalis. Traditionally, surgical excision and or repair under general anaesthesia has been the standard of care, but sclerosant therapy can be used safely and with efficacy for hydrocele’s treatment. This study aims to review and elucidate the current literature sclerotherapy for hydrocele. We searched for articles in Pubmed, Embase and Cochrane evaluating aspiration and sclerotherapy for hydrocele treatment. Search terms were “hydrocele” and “sclerotherapy”. Relevant papers references were full reviewed searching for new articles. The sclerosing agents considered eligle were phenol, tetracycline, sodium tetradecyl sulfate, phenol and alcohol. We included 1554 patients from 26 studies. Mean aspirative hydrocele volume was 238,3 mL. Cure rate was seen in 58,3% to 76% after a single procedure in STDS studies and 70% to 94,11% overall success. Phenol’s studies demonstrated a 47.5% to 70% cure rate with one sclerotherapy and 96.5% to 100% overall success. In Sclerotheraphy with tetracycline cure rate after a single procedure was 57% to 100% and overall success was 77% to 100%. Of the polidocanol group, cure rate was 42.3% to 62.1% after one sclerotherapy and overall success was 51.7% to 94%. Finally, in alcohol’s group we found 50% to 76.12% after one procedure and 80% to 97.62%. A better cure rate after one procedure was observed with tetracycline and overall success after multiples procedures was seen with phenol. Due to heterogeneity and biases of the studies, more controlled clinical trials must be done to elucidate the best sclerosant agents. No conflict.
{"title":"(O-24) EFFICACY OF ASPIRATION AND SCLEROTHERAPY FOR HYDROCELE: A SYSTEMATIC REVIEW","authors":"F. C. Freitas, M. R. Sanches, AdC Dosatti","doi":"10.1093/jsxmed/qdae018.018","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.018","url":null,"abstract":"\u0000 \u0000 \u0000 Hydroceles are abnormal collection of fluid between the parietal and visceral layers of the tunica vaginalis. Traditionally, surgical excision and or repair under general anaesthesia has been the standard of care, but sclerosant therapy can be used safely and with efficacy for hydrocele’s treatment. This study aims to review and elucidate the current literature sclerotherapy for hydrocele.\u0000 \u0000 \u0000 \u0000 We searched for articles in Pubmed, Embase and Cochrane evaluating aspiration and sclerotherapy for hydrocele treatment. Search terms were “hydrocele” and “sclerotherapy”. Relevant papers references were full reviewed searching for new articles. The sclerosing agents considered eligle were phenol, tetracycline, sodium tetradecyl sulfate, phenol and alcohol.\u0000 \u0000 \u0000 \u0000 We included 1554 patients from 26 studies. Mean aspirative hydrocele volume was 238,3 mL. Cure rate was seen in 58,3% to 76% after a single procedure in STDS studies and 70% to 94,11% overall success. Phenol’s studies demonstrated a 47.5% to 70% cure rate with one sclerotherapy and 96.5% to 100% overall success. In Sclerotheraphy with tetracycline cure rate after a single procedure was 57% to 100% and overall success was 77% to 100%. Of the polidocanol group, cure rate was 42.3% to 62.1% after one sclerotherapy and overall success was 51.7% to 94%. Finally, in alcohol’s group we found 50% to 76.12% after one procedure and 80% to 97.62%.\u0000 \u0000 \u0000 \u0000 A better cure rate after one procedure was observed with tetracycline and overall success after multiples procedures was seen with phenol. Due to heterogeneity and biases of the studies, more controlled clinical trials must be done to elucidate the best sclerosant agents.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"50 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140378508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.035
V. F. N. Lima, GECd Almeida, P. D. C. Gamberini, C. Milanez, D. C. Lucas, G. R. Bechara, C. F. Borges
Erectile Dysfunction (ED) refers to the inability to achieve or sustain a satisfactory erection for sexual intercourse. In Brazil, the estimated prevalence of ED among adults aged 40 to 70 years is 42.1%. For the evaluation of primary erectile dysfunction and preoperative assessment of Peyronie's disease, Penile Doppler ultrasound, involving drug-induced is recommended. This study aims to provide insights into the epidemiology of patients undergoing penile Doppler ultrasound at a Federal University Hospital. This retrospective study gathered data from the electronic medical records of 179 patients who underwent the examination between March 2021 and March 2023, using the Phillips Affiniti 50G device. Pharmacological induction with 10 mcg/ml Alprostadil, 30 mg/ml Papaverine, and 1 mg/ml Phentolamine. Initially, 0.1 ml of this mixture was applied to the penile shaft, with subsequent adjustments made to achieve the best maximal erection. The participants ages ranged from 20 to 80 years, with an average of 59.8(±11,42) years. Marital status distribution showed 139 married and 40 were single. Ethnically, there were 57 white, 69 individuals of mixed race, and 39 black. The average Body Mass Index was 26.6(±4,13). The majority of patients identified as heterosexual (174 patients), with 51 cases of hypertension and 31 cases of diabetes. Additionally, 62 patients had radical prostatectomy. Out of the 134 patients that performed the exam with the report of erectile dysfunction, 54 were diagnosed with arterial insufficiency and 09 had venous leakage. Among the 42 exlcusive clinical report of Peyronie’s, 76% exhibited a uniplanar curvature located in the dorsal region. The average curvature angle was 47°(±19,5). Erectile dysfunction was significantly more prevalent than Peyronie's disease. Among Peyronie's patients, uniplanar curvature, especially in the dorsal region, was the most common deformity type. No conflict.
{"title":"(PM-03) EPIDEMIOLOGICAL PROFILE OF PATIENTS UNDERGOING PENILE DOPPLER ULTRASOUND AT A FEDERAL UNIVERSITY HOSPITAL IN BRAZIL","authors":"V. F. N. Lima, GECd Almeida, P. D. C. Gamberini, C. Milanez, D. C. Lucas, G. R. Bechara, C. F. Borges","doi":"10.1093/jsxmed/qdae018.035","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.035","url":null,"abstract":"\u0000 \u0000 \u0000 Erectile Dysfunction (ED) refers to the inability to achieve or sustain a satisfactory erection for sexual intercourse. In Brazil, the estimated prevalence of ED among adults aged 40 to 70 years is 42.1%. For the evaluation of primary erectile dysfunction and preoperative assessment of Peyronie's disease, Penile Doppler ultrasound, involving drug-induced is recommended. This study aims to provide insights into the epidemiology of patients undergoing penile Doppler ultrasound at a Federal University Hospital.\u0000 \u0000 \u0000 \u0000 This retrospective study gathered data from the electronic medical records of 179 patients who underwent the examination between March 2021 and March 2023, using the Phillips Affiniti 50G device. Pharmacological induction with 10 mcg/ml Alprostadil, 30 mg/ml Papaverine, and 1 mg/ml Phentolamine. Initially, 0.1 ml of this mixture was applied to the penile shaft, with subsequent adjustments made to achieve the best maximal erection.\u0000 \u0000 \u0000 \u0000 The participants ages ranged from 20 to 80 years, with an average of 59.8(±11,42) years. Marital status distribution showed 139 married and 40 were single. Ethnically, there were 57 white, 69 individuals of mixed race, and 39 black. The average Body Mass Index was 26.6(±4,13). The majority of patients identified as heterosexual (174 patients), with 51 cases of hypertension and 31 cases of diabetes. Additionally, 62 patients had radical prostatectomy. Out of the 134 patients that performed the exam with the report of erectile dysfunction, 54 were diagnosed with arterial insufficiency and 09 had venous leakage. Among the 42 exlcusive clinical report of Peyronie’s, 76% exhibited a uniplanar curvature located in the dorsal region. The average curvature angle was 47°(±19,5).\u0000 \u0000 \u0000 \u0000 Erectile dysfunction was significantly more prevalent than Peyronie's disease. Among Peyronie's patients, uniplanar curvature, especially in the dorsal region, was the most common deformity type.\u0000 \u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"121 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140379003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.029
M. Castiglione, E. Silva Cardoso, V. D. De Avila, N. Maas Soldi, D. Marques Nicastro, S. Moura Rodrigues, F. Benetti, A. Estevão, N. Lie Utiyamada, S. Glina
Female sexual dysfunctions (FSD) can influence physical and mental health, causing limitations in the ability to respond to or enjoy sexual pleasure. Studies show that overweight and obesity can lead to the onset of FSD, but the evidence found remains conflicting. To investigate and compare the sexual function of women between 18 and 50 years old, obese, overweight and eutrophic. Observational and comparative study. A link to the questionnaire was sent through social networks to women between 18 and 50 years old, sexually active in the last four weeks before answering the questionnaire, after agreeing to participate in the study and signing the consent form, they filled out a form. with demographic data and the Female Sexual Function Index questionnaire, postmenopausal women were excluded from the survey. This study was approved by the ethics and research committee of the FMABC University Center with opinion number: 4,229,411. 325 women participated in the study, with an average age of 28 years, where 186 were classified as obese (49.60%), 109 as overweight (29.07%) and 80 as obese (21.33%, the majority married in a stable union). . union (50.13%) or single (42.93%).In the total score of the FSFI questionnaire (median), non-obese participants obtained 16.4 points, overweight participants obtained 16.4 points, and obese participants they obtained 17.1, without significant difference. in the comparison of DSF according to BMI classification (p=0.887). There were no statistically significant results on sexual function in obese, overweight and normal weight women in the study. No conflict.
{"title":"(O-38) SEXUAL FUNCTION OF WOMEN WITH NORMAL WEIGHT, OVERWEIGHT AND OBESITY FROM 18 TO 50 YEARS OLD","authors":"M. Castiglione, E. Silva Cardoso, V. D. De Avila, N. Maas Soldi, D. Marques Nicastro, S. Moura Rodrigues, F. Benetti, A. Estevão, N. Lie Utiyamada, S. Glina","doi":"10.1093/jsxmed/qdae018.029","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.029","url":null,"abstract":"\u0000 \u0000 \u0000 Female sexual dysfunctions (FSD) can influence physical and mental health, causing limitations in the ability to respond to or enjoy sexual pleasure. Studies show that overweight and obesity can lead to the onset of FSD, but the evidence found remains conflicting.\u0000 \u0000 \u0000 \u0000 To investigate and compare the sexual function of women between 18 and 50 years old, obese, overweight and eutrophic.\u0000 \u0000 \u0000 \u0000 Observational and comparative study. A link to the questionnaire was sent through social networks to women between 18 and 50 years old, sexually active in the last four weeks before answering the questionnaire, after agreeing to participate in the study and signing the consent form, they filled out a form. with demographic data and the Female Sexual Function Index questionnaire, postmenopausal women were excluded from the survey. This study was approved by the ethics and research committee of the FMABC University Center with opinion number: 4,229,411.\u0000 \u0000 \u0000 \u0000 325 women participated in the study, with an average age of 28 years, where 186 were classified as obese (49.60%), 109 as overweight (29.07%) and 80 as obese (21.33%, the majority married in a stable union). . union (50.13%) or single (42.93%).In the total score of the FSFI questionnaire (median), non-obese participants obtained 16.4 points, overweight participants obtained 16.4 points, and obese participants they obtained 17.1, without significant difference. in the comparison of DSF according to BMI classification (p=0.887).\u0000 \u0000 \u0000 \u0000 There were no statistically significant results on sexual function in obese, overweight and normal weight women in the study.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"102 49","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140379578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.025
A. P. Soster, D. Falcke, A. M. Oliveira
This study aimed to verify the association between sexual agency and sexual satisfaction in Portuguese and Brazilian university students. 322 university students, 161 Brazilian and 161 Portuguese, aged between 18 and 29, took part in this cross-sectional study by answering an online questionnaire. The measures used were a sociodemographic questionnaire, the Sexual Attitudes Scale, the New Sexual Satisfaction Scale and the Sexual Assertiveness Scale. The data was analyzed using descriptive statistics and Spearman correlation. Ethical procedures were met. The measures of individual sexual satisfaction (BR 0.446/PT 0.499), relational sexual satisfaction and in sexual satisfaction of sexual activity (BR 0.375/PT 0.363), and total sexual satisfaction (BR 0.454/PT 0.458), showed significant (p<0.01) moderate positive associations with the dimension of sexual assertiveness initiation, related to sexual agency to initiate sexual relations and communicate desires to the partner in both groups. This is a finding that contradicts the rules associated with traditional sexual scripts, which advocate that women tend to behave passively in relation to their partner's desires. The association between initiative and sexual satisfaction demonstrates the need to go against traditional sexual scripts, encouraging women to recognize and communicate their desires, and to validate the right to pleasure and sexual satisfaction. Expanding communication and listening to desires, opening up to different ways of giving and receiving physical pleasure, can increase the feeling of desire and the possibility of feeling desired, favoring the possibility of individual and shared pleasure and satisfaction. No conflict.
{"title":"(O-31) ASSOCIATION BETWEEN SEXUAL AGENCY AND SEXUAL SATISFACTION IN BRAZILIAN AND PORTUGUESE UNIVERSITY STUDENTS","authors":"A. P. Soster, D. Falcke, A. M. Oliveira","doi":"10.1093/jsxmed/qdae018.025","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.025","url":null,"abstract":"\u0000 \u0000 \u0000 This study aimed to verify the association between sexual agency and sexual satisfaction in Portuguese and Brazilian university students.\u0000 \u0000 \u0000 \u0000 322 university students, 161 Brazilian and 161 Portuguese, aged between 18 and 29, took part in this cross-sectional study by answering an online questionnaire. The measures used were a sociodemographic questionnaire, the Sexual Attitudes Scale, the New Sexual Satisfaction Scale and the Sexual Assertiveness Scale. The data was analyzed using descriptive statistics and Spearman correlation. Ethical procedures were met.\u0000 \u0000 \u0000 \u0000 The measures of individual sexual satisfaction (BR 0.446/PT 0.499), relational sexual satisfaction and in sexual satisfaction of sexual activity (BR 0.375/PT 0.363), and total sexual satisfaction (BR 0.454/PT 0.458), showed significant (p<0.01) moderate positive associations with the dimension of sexual assertiveness initiation, related to sexual agency to initiate sexual relations and communicate desires to the partner in both groups. This is a finding that contradicts the rules associated with traditional sexual scripts, which advocate that women tend to behave passively in relation to their partner's desires.\u0000 \u0000 \u0000 \u0000 The association between initiative and sexual satisfaction demonstrates the need to go against traditional sexual scripts, encouraging women to recognize and communicate their desires, and to validate the right to pleasure and sexual satisfaction. Expanding communication and listening to desires, opening up to different ways of giving and receiving physical pleasure, can increase the feeling of desire and the possibility of feeling desired, favoring the possibility of individual and shared pleasure and satisfaction.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"105 41","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140380468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.019
F. C. de Freitas, M. R. Sanches, AdC Dosatti
Chronic testicular pain (CTP) is defined as 3 months of intermittent or constant testicular pain that is significantly bothersome to the patient. There exist a variety of different surgical treatment options for CTP. They are generally kept as second or even third-line option for persistent cases. This study aims to review and elucidate the literature about surgical treatment for chronic testicular pain. We searched Pubmed, Embase and Cochrane for articles evaluating surgical treatments for CTP. Search terms included “orchialgia”, “spermatic cord”, “chronic scrotal pain”, “chronic testicular pain” and “surgery”. Microsurgical Denervation of the Spermatic Cord (MDSC) is the surgical standard when a procedure is indicated for idiopathic chronic orchialgia unresponsive to conservative therapies. The positive response to spermatic cord block is a predictor of MDSC response. Pain relief after MDSC ranges from 76% to 100%. Ultrasound-guided targeted cryoablation could be used in persistent CTP after MDSC with 75% success rate. Epididymectomy is better indicated for CTP in structural abnormality such as cyst, granuloma or mass, with pain relief reaching 50% to 92%. In case of post-vasectomy pain syndrome, vasectomy reversal and MDSC has an overall success from 50% to 100% and 71% to 81% respectively. Ilioinguinal and genitofemoral peripheral nerve stimulation could be used in persistant CTP, and spinal cord stimulation as well. Orchiectomy can be considered as a last resort in case patients do not respond to other forms of treatment, but do not delivers a 100% relief a pain. Although it’s variables choices, there is not a gold standard surgical treatment for CTP, representing a challenge for clinicians. Large, controlled trials must be performed to establish strong and reliable evidence for the surgical treatment of CTP. No conflict.
{"title":"(O-25) SURGICAL TREATMENT FOR CHRONIC TESTICULAR PAIN: A SYSTEMATIC REVIEW","authors":"F. C. de Freitas, M. R. Sanches, AdC Dosatti","doi":"10.1093/jsxmed/qdae018.019","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.019","url":null,"abstract":"\u0000 \u0000 \u0000 Chronic testicular pain (CTP) is defined as 3 months of intermittent or constant testicular pain that is significantly bothersome to the patient. There exist a variety of different surgical treatment options for CTP. They are generally kept as second or even third-line option for persistent cases. This study aims to review and elucidate the literature about surgical treatment for chronic testicular pain.\u0000 \u0000 \u0000 \u0000 We searched Pubmed, Embase and Cochrane for articles evaluating surgical treatments for CTP. Search terms included “orchialgia”, “spermatic cord”, “chronic scrotal pain”, “chronic testicular pain” and “surgery”.\u0000 \u0000 \u0000 \u0000 Microsurgical Denervation of the Spermatic Cord (MDSC) is the surgical standard when a procedure is indicated for idiopathic chronic orchialgia unresponsive to conservative therapies. The positive response to spermatic cord block is a predictor of MDSC response. Pain relief after MDSC ranges from 76% to 100%. Ultrasound-guided targeted cryoablation could be used in persistent CTP after MDSC with 75% success rate. Epididymectomy is better indicated for CTP in structural abnormality such as cyst, granuloma or mass, with pain relief reaching 50% to 92%. In case of post-vasectomy pain syndrome, vasectomy reversal and MDSC has an overall success from 50% to 100% and 71% to 81% respectively. Ilioinguinal and genitofemoral peripheral nerve stimulation could be used in persistant CTP, and spinal cord stimulation as well. Orchiectomy can be considered as a last resort in case patients do not respond to other forms of treatment, but do not delivers a 100% relief a pain.\u0000 \u0000 \u0000 \u0000 Although it’s variables choices, there is not a gold standard surgical treatment for CTP, representing a challenge for clinicians. Large, controlled trials must be performed to establish strong and reliable evidence for the surgical treatment of CTP.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"122 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140381021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.033
J. M. Silva-Herrera, C. Martínez-Pinedo, D. Varela-Herrera, J. M. Huertas-Cañas, J. S. García-Torres
Erectile dysfunction is defined as the persistent inability to achieve or maintain an erection sufficient for a satisfactory sexual relationship. In some cases, it is refractory to pharmacological treatments, or these treatments are contraindicated, leading to the consideration of using a penile prosthesis as a definitive treatment. While reported patient and partner satisfaction rates are high (82 – 97%), dissatisfaction has been found to be attributed to various reasons, including prosthesis dysfunction and/or unmet patient expectations regarding the quality of the erection and sexual satisfaction. An analytical observational bidirectional cohort study approved by the institutional ethics committee was conducted. Subsequently, patients who underwent penile prosthesis implantation between January 2017 and June 2021 at a single center were identified. A total of 47 cases were analyzed, with an average age of 64 years. Overall satisfaction with the penile prosthesis implantation was 100%. 94.1% felt that their treatment expectations were met, 88.2% reported continuing to use this method, and 100% were satisfied with the duration of the erection. A 100% overall global satisfaction rate was observed. High rates of sexual satisfaction in patients were evident, reaffirming the penile prosthesis as a safe procedure that should be offered as a third-line treatment or when a permanent solution is desired. No conflict.
{"title":"(PM-01) SEXUAL SATISFACTION POST PENILE PROSTHESIS IMPLANTATION","authors":"J. M. Silva-Herrera, C. Martínez-Pinedo, D. Varela-Herrera, J. M. Huertas-Cañas, J. S. García-Torres","doi":"10.1093/jsxmed/qdae018.033","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.033","url":null,"abstract":"\u0000 \u0000 \u0000 Erectile dysfunction is defined as the persistent inability to achieve or maintain an erection sufficient for a satisfactory sexual relationship. In some cases, it is refractory to pharmacological treatments, or these treatments are contraindicated, leading to the consideration of using a penile prosthesis as a definitive treatment. While reported patient and partner satisfaction rates are high (82 – 97%), dissatisfaction has been found to be attributed to various reasons, including prosthesis dysfunction and/or unmet patient expectations regarding the quality of the erection and sexual satisfaction.\u0000 \u0000 \u0000 \u0000 An analytical observational bidirectional cohort study approved by the institutional ethics committee was conducted. Subsequently, patients who underwent penile prosthesis implantation between January 2017 and June 2021 at a single center were identified.\u0000 \u0000 \u0000 \u0000 A total of 47 cases were analyzed, with an average age of 64 years. Overall satisfaction with the penile prosthesis implantation was 100%. 94.1% felt that their treatment expectations were met, 88.2% reported continuing to use this method, and 100% were satisfied with the duration of the erection.\u0000 \u0000 \u0000 \u0000 A 100% overall global satisfaction rate was observed. High rates of sexual satisfaction in patients were evident, reaffirming the penile prosthesis as a safe procedure that should be offered as a third-line treatment or when a permanent solution is desired.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"39 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140378377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.036
E. Marcio Cardoso, D. da Costa Merino, T. Fernandes Torres, M. Castiglione, R. Pavione Rodrigues Pereira, C. Tanaka
Erectile dysfunction, premature ejaculation, retrograde ejaculation, delayed ejaculation, anejaculation, painful ejaculation, anorgasmia, hematospermia and low sexual desire are the main male sexual dysfunctions. The 2022 European Association of Urology recommends the use of vibratory stimulation and vacuum erection devices in the treatment of male sexual dysfunctions (mainly anejaculation and erectile dysfunction), both as adjuvant therapy and as combination therapy with other interventions. The objective of the study was to verify if there is scientific evidence for the use of vibrating stimulation and the vacuum erection device in male sexual dysfunctions that allow clinical indication in an effective and safe manner. Literature review by searching for scientific articles in the Pubmed database of the National Library of Medicine published in the last 10 years, including randomized clinical trials, meta-analysis studies, pilot studies, systematic literature reviews and guidelines. As a result 1,230 articles on male sexual dysfunction. After screening, 16 studies were selected that are part of this research, seven articles on vibratory stimulation and nine on vacuum erection devices. This review suggests that vacuum erection and vibratory stimulation devices, as they offer low risk, minimal side effects, are accessible and cost-effective compared to other approaches, are promising devices for the non-invasive treatment of male dysfunctions. sex. Other studies with greater methodological rigor are needed. Vibratory stimulation; sexual dysfunction; penis vibrator; male sexual dysfunction; vacuum erectile; vacuum erection; Peyronie's disease No conflict.
{"title":"(PM-04) EFFECTS OF VIBRATORY STIMULATION AND VACUUM ERECTION DEVICE IN THE TREATMENT OF MALE SEXUAL DYSFUNCTIONS: A LITERATURE REVIEW","authors":"E. Marcio Cardoso, D. da Costa Merino, T. Fernandes Torres, M. Castiglione, R. Pavione Rodrigues Pereira, C. Tanaka","doi":"10.1093/jsxmed/qdae018.036","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.036","url":null,"abstract":"\u0000 \u0000 \u0000 Erectile dysfunction, premature ejaculation, retrograde ejaculation, delayed ejaculation, anejaculation, painful ejaculation, anorgasmia, hematospermia and low sexual desire are the main male sexual dysfunctions. The 2022 European Association of Urology recommends the use of vibratory stimulation and vacuum erection devices in the treatment of male sexual dysfunctions (mainly anejaculation and erectile dysfunction), both as adjuvant therapy and as combination therapy with other interventions. The objective of the study was to verify if there is scientific evidence for the use of vibrating stimulation and the vacuum erection device in male sexual dysfunctions that allow clinical indication in an effective and safe manner.\u0000 \u0000 \u0000 \u0000 Literature review by searching for scientific articles in the Pubmed database of the National Library of Medicine published in the last 10 years, including randomized clinical trials, meta-analysis studies, pilot studies, systematic literature reviews and guidelines.\u0000 \u0000 \u0000 \u0000 As a result 1,230 articles on male sexual dysfunction. After screening, 16 studies were selected that are part of this research, seven articles on vibratory stimulation and nine on vacuum erection devices.\u0000 \u0000 \u0000 \u0000 This review suggests that vacuum erection and vibratory stimulation devices, as they offer low risk, minimal side effects, are accessible and cost-effective compared to other approaches, are promising devices for the non-invasive treatment of male dysfunctions. sex. Other studies with greater methodological rigor are needed.\u0000 \u0000 \u0000 \u0000 Vibratory stimulation; sexual dysfunction; penis vibrator; male sexual dysfunction; vacuum erectile; vacuum erection; Peyronie's disease\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"8 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140378718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.032
I. Silva, A. Naccarato, JdAeS Campos, F. Denardi, W. E. Matheus, U. Ferreira
The incidence of cancer in the world population in 2002 was estimated at 11 million new cases, in 2020 this estimate is approximately 20 million. Cancer is a global public health problem. Prostate cancer (CaP) is a multifocal disease, with wide clinical variation among patients. The PCa survivors present unique chronic side effects compared to other cancer survivors, with challenges in achieving physical and social well-being, and satisfaction with life in general. This work aims to evaluate the impact of psychotherapy, in an open group, on Health-Related Quality of Life (HRQoL) and Sexuality in patients with PCa who have undergone treatment. Data is been collected through an initial interview (Identification, Anamnesis, Health Anamnesis, Degree of Satisfaction with Life and Sexuality, Affective-Emotional Assessment and Treatment Data), SF-36 questionnaire and IIEF-5 short form, in patients who are diagnosed, have undergone treatment or are being monitored at the outpatient clinic, and reapplication in the last semester of the group's operation. At each session, 5 questions are answered regarding the perception of the previous session. The group will be available once a week for 2 years. The sessions last 90 minutes, led by the same psychologist. The research is been developed considering the ethical principles of secrecy, privacy, confidentiality and non-identification of interviewee data. The study will not pose any risks to the subjects and no invasive techniques will be used to deal with the body or psychological distress. Before starting the process, the Termo de Consentimento Livre e Esclarecido (TCLE) is delivered, as well as the provision of all details regarding the research. It is also explained that participation is voluntary and that the participant may leave the research at any time, without this causing any harm to their treatment and follow-up. No conflict.
{"title":"(O-41) PSYCHOEDUCATIONAL GROUP FOR MEN WITH PROSTATE CANCER","authors":"I. Silva, A. Naccarato, JdAeS Campos, F. Denardi, W. E. Matheus, U. Ferreira","doi":"10.1093/jsxmed/qdae018.032","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.032","url":null,"abstract":"\u0000 \u0000 \u0000 The incidence of cancer in the world population in 2002 was estimated at 11 million new cases, in 2020 this estimate is approximately 20 million. Cancer is a global public health problem.\u0000 Prostate cancer (CaP) is a multifocal disease, with wide clinical variation among patients. The PCa survivors present unique chronic side effects compared to other cancer survivors, with challenges in achieving physical and social well-being, and satisfaction with life in general.\u0000 This work aims to evaluate the impact of psychotherapy, in an open group, on Health-Related Quality of Life (HRQoL) and Sexuality in patients with PCa who have undergone treatment. Data is been collected through an initial interview (Identification, Anamnesis, Health Anamnesis, Degree of Satisfaction with Life and Sexuality, Affective-Emotional Assessment and Treatment Data), SF-36 questionnaire and IIEF-5 short form, in patients who are diagnosed, have undergone treatment or are being monitored at the outpatient clinic, and reapplication in the last semester of the group's operation. At each session, 5 questions are answered regarding the perception of the previous session. The group will be available once a week for 2 years. The sessions last 90 minutes, led by the same psychologist. The research is been developed considering the ethical principles of secrecy, privacy, confidentiality and non-identification of interviewee data. The study will not pose any risks to the subjects and no invasive techniques will be used to deal with the body or psychological distress. Before starting the process, the Termo de Consentimento Livre e Esclarecido (TCLE) is delivered, as well as the provision of all details regarding the research. It is also explained that participation is voluntary and that the participant may leave the research at any time, without this causing any harm to their treatment and follow-up.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"115 39","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140379073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.042
L. I. Maia Fontes, D. da Costa Merino, T. Fernandes Torres, M. Castiglione, R. Pavione Rodrigues Pereira, C. Tanaka
There are several aspects that involve the sexual function of an individual, such as biological, psychological and interpersonal factors. Based on this, symptoms of female sexual dysfunction are classified according to the response phase of the affected sexual cycle. In physiotherapy there are some resources that are used for the treatment of sexual dysfunctions, including vibration, which is used with the aim of improving muscle condition and vascularization, but the real effects of applying this technique in the treatment are not known. of sexual dysfunctions. Thus, the objective of this study was to identify evidence on the benefits of vibration in female sexual dysfunctions. The PubMed and VHL databases were searched according to a search strategy defined by PICOS: ((((sexuality) OR (sexual dysfunction)) OR (pelvic floor disorders)) OR (women's health)) AND (vibration), which included systematic reviews, meta-analyses and clinical trials from 2012 to 2022 that approached vibration as a resource investigated or used in female sexual dysfunctions. Other study designs were excluded, as well as those that did not use vibration as a resource or that were aimed solely at the male audience. A total of 89 articles were found, of which 83 were excluded for not meeting the inclusion criteria; six articles were selected to compose this review. Among the selected articles, three brought vibration as a purely evaluative resource, and three articles also looked for evidence on the use of vibration as a treatment for female sexual dysfunctions. No studies were found in which vibration has been used as a therapeutic resource in female sexual dysfunctions, which opens precedents for future studies in this regard. No conflict.
{"title":"(PM-14) THE USE OF VIBRATIONS IN FEMALE SEXUAL DYSFUNCTIONS: NARRATIVE REVIEW OF THE LITERATURE","authors":"L. I. Maia Fontes, D. da Costa Merino, T. Fernandes Torres, M. Castiglione, R. Pavione Rodrigues Pereira, C. Tanaka","doi":"10.1093/jsxmed/qdae018.042","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.042","url":null,"abstract":"\u0000 \u0000 \u0000 There are several aspects that involve the sexual function of an individual, such as biological, psychological and interpersonal factors. Based on this, symptoms of female sexual dysfunction are classified according to the response phase of the affected sexual cycle. In physiotherapy there are some resources that are used for the treatment of sexual dysfunctions, including vibration, which is used with the aim of improving muscle condition and vascularization, but the real effects of applying this technique in the treatment are not known. of sexual dysfunctions. Thus, the objective of this study was to identify evidence on the benefits of vibration in female sexual dysfunctions.\u0000 \u0000 \u0000 \u0000 The PubMed and VHL databases were searched according to a search strategy defined by PICOS: ((((sexuality) OR (sexual dysfunction)) OR (pelvic floor disorders)) OR (women's health)) AND (vibration), which included systematic reviews, meta-analyses and clinical trials from 2012 to 2022 that approached vibration as a resource investigated or used in female sexual dysfunctions. Other study designs were excluded, as well as those that did not use vibration as a resource or that were aimed solely at the male audience.\u0000 \u0000 \u0000 \u0000 A total of 89 articles were found, of which 83 were excluded for not meeting the inclusion criteria; six articles were selected to compose this review. Among the selected articles, three brought vibration as a purely evaluative resource, and three articles also looked for evidence on the use of vibration as a treatment for female sexual dysfunctions.\u0000 \u0000 \u0000 \u0000 No studies were found in which vibration has been used as a therapeutic resource in female sexual dysfunctions, which opens precedents for future studies in this regard.\u0000 \u0000 \u0000 \u0000 No conflict.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"115 45","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140380183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-26DOI: 10.1093/jsxmed/qdae018.014
H. Corredor, J. M. Martínez, C. Sandoval-Salinas, J. Barba, F. Patrón
Multiple treatment modalities have been used to treat erectile dysfunction (ED), including focal shock waves. This therapy has demonstrated a short-term positive effect in patients who respond or not to PDE-5i, with variability in therapeutic protocols. To evaluate the effectiveness of 3 shock wave protocols for the treatment of ED. Randomized, multicenter clinical trial. 277 men with non-psychological ED, over 18 years of age, without cancer or major surgeries in the pelvic area or any neurological disease that affected their erectile function, were randomized to one of three groups: weekly (6 wave sessions (WS), 1 x wk), monthly (6 WS 1 x month) or reinforcement (6 WS, 1 x week + 5 sessions, 1 x month). The wave parameters were the same in all groups, no patient received medication. The primary outcome was the change in IIEF-EF score at 6 months of follow-up. The change in the IIEF at the end of therapy and at 3 months of follow-up, erection hardness with the EHS, self-esteem with the SEAR questionnaire, and side effects were also evaluated. 222 patients completed the study. In the 6-month evaluation, the average change in the IIEF-EF in the monthly schedule was 4.3 (+/-6.7), 1.9 (+/-6.5) in the weekly schedule, and 5.0 (+/-6.1) in the reinforcement schedule ( p=0.0086). At the end of therapy and at 3 months the change in the IIEF-EF was 3.2 (+/-5.8) and 2.9 (+/-5.5) in the monthly group, 2.7 (+/-4.5) and 3.0 (+/-5.3) in the weekly one, and 4.2 (+/-6.4) and 4.4 (+/-6.5) in the reinforcement one. No differences were found between the groups in the proportion of patients who increased at least one point in erection hardness, nor in the average in the SEAR questionnaire in the evaluations carried out. No patient reported adverse effects to the therapy. The results suggest that monthly and reinforcement wave schemes present good results for the treatment of ED. Boston Medical Group.
{"title":"(O-20) COMPARISON OF THREE SHOCKWAVE THERAPY PROTOCOLS FOR THE TREATMENT OF ERECTILE DYSFUNCTION","authors":"H. Corredor, J. M. Martínez, C. Sandoval-Salinas, J. Barba, F. Patrón","doi":"10.1093/jsxmed/qdae018.014","DOIUrl":"https://doi.org/10.1093/jsxmed/qdae018.014","url":null,"abstract":"\u0000 \u0000 \u0000 Multiple treatment modalities have been used to treat erectile dysfunction (ED), including focal shock waves. This therapy has demonstrated a short-term positive effect in patients who respond or not to PDE-5i, with variability in therapeutic protocols.\u0000 \u0000 \u0000 \u0000 To evaluate the effectiveness of 3 shock wave protocols for the treatment of ED.\u0000 \u0000 \u0000 \u0000 Randomized, multicenter clinical trial. 277 men with non-psychological ED, over 18 years of age, without cancer or major surgeries in the pelvic area or any neurological disease that affected their erectile function, were randomized to one of three groups: weekly (6 wave sessions (WS), 1 x wk), monthly (6 WS 1 x month) or reinforcement (6 WS, 1 x week + 5 sessions, 1 x month). The wave parameters were the same in all groups, no patient received medication. The primary outcome was the change in IIEF-EF score at 6 months of follow-up. The change in the IIEF at the end of therapy and at 3 months of follow-up, erection hardness with the EHS, self-esteem with the SEAR questionnaire, and side effects were also evaluated.\u0000 \u0000 \u0000 \u0000 222 patients completed the study. In the 6-month evaluation, the average change in the IIEF-EF in the monthly schedule was 4.3 (+/-6.7), 1.9 (+/-6.5) in the weekly schedule, and 5.0 (+/-6.1) in the reinforcement schedule ( p=0.0086). At the end of therapy and at 3 months the change in the IIEF-EF was 3.2 (+/-5.8) and 2.9 (+/-5.5) in the monthly group, 2.7 (+/-4.5) and 3.0 (+/-5.3) in the weekly one, and 4.2 (+/-6.4) and 4.4 (+/-6.5) in the reinforcement one. No differences were found between the groups in the proportion of patients who increased at least one point in erection hardness, nor in the average in the SEAR questionnaire in the evaluations carried out. No patient reported adverse effects to the therapy.\u0000 \u0000 \u0000 \u0000 The results suggest that monthly and reinforcement wave schemes present good results for the treatment of ED.\u0000 \u0000 \u0000 \u0000 \u0000 Boston Medical Group.\u0000","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"123 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140380857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：